Search all trials

Find therapies in clinical trials near you – page 16

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Adenocarcinoma gastric

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Lenvatinib, Pembrolizumab, and Chemotherapy for Patients with Advanced or Metastatic Gastroesophageal Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Bladder cancer+2

Not recruiting

Registered drug

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older

Registered drugNo placebo

Belgium

Participants:65+ years
Substances:Cyclophosphamide

Contact Research Centre

Follicular lymphoma+1

Not recruiting

Registered drug

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Study on the Safety and Effectiveness of Epcoritamab with a Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Epcoritamab with a Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Non-small cell lung cancer stage III

Not recruiting

Registered drugNo placebo

Study of Nivolumab and Ipilimumab for Patients with Stage 3 Non-Small Cell Lung Cancer Not Suitable for Surgery

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Microsatellite instability cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Primary amyloidosis

Not recruiting

Registered drug

Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Birtamimab

Contact Research Centre

Find therapies in clinical trials near you – page 16

192 trials match your criteria

Adenocarcinoma gastric

Study on the Effectiveness and Safety of Lenvatinib, Pembrolizumab, and Chemotherapy for Patients with Advanced or Metastatic Gastroesophageal Cancer

Bladder cancer+2

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Diffuse large B-cell lymphoma

Study on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older

Follicular lymphoma+1

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Study on the Safety and Effectiveness of Epcoritamab with a Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

Study on the Safety and Effectiveness of Epcoritamab with a Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

Non-small cell lung cancer stage III

Study of Nivolumab and Ipilimumab for Patients with Stage 3 Non-Small Cell Lung Cancer Not Suitable for Surgery

Colitis ulcerative

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Malignant melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Hodgkin's disease

Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Microsatellite instability cancer+1

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Non-small cell lung cancer

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Primary amyloidosis

Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.